Volume 2 Issue 8
Immunotherapy and Acute Lymphoblastic Leukemia
Timothy Allen* MD, Ph.D, Giridhar M.N.V, MD, MBA, Ghazaleh Shoja E Razavi MD
Acute lymphoblastic leukemia is a serious type of cancer that originates from the development and differentiation o the early version of lymphocytes in the bone marrow. With the advent of new technologies and discoveries, novel therapeutics were developed to treat these malignancies. Targeted immunotherapies are drugs that block the growth and spread of the cancer by interfering with specific molecules or pathways that are involved in carcinogenesis. It is a developing treatment alternative to chemotherapy and radiation. In this paper, we will discuss the current trends in various target therapies along with the different molecules involved in the proliferation of the disease.
Is there A Standard Strategy for Managing Gall Bladder Polyps?
Abd Elrafea Elkak*
Polypoid lesions of the gall bladder may be defined as elevations of the gall bladder mucosa. They are a common problem in clinical practice. More polypoid lesions of the gall bladder are detected with the increasing use of ultrasound and CT in clinical practice. Because of the risk of malignant transformation and the well known dismal prognosis of gall bladder cancer, it is important to establish a management strategy for gall bladder polyps.